Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin IV to Oral Switch in Japanese Adults with CAP
NCT00809328Phase 3Completed
- Sponsor
- Pfizer
- Start
- Feb 2009
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azithromycin in community acquired pneumonia (CAP), sponsored by Pfizer. Started Feb 2009; status: completed.
02
Drugs
azithromycin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT00809328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00809328.